Table 1.
Baseline clin1ical characteristics of patients who completed the study.
| UC group | IC group | P value | |
|---|---|---|---|
| N | 22 | 19 | |
| Age (years) | 61.3 (9.8) | 59.1 (15.6) | 0.6 |
| Men (%) | 59 | 79 | 0.2 |
| BMI (kg/m2) | 26.5 (3.5) | 26.4 (4.1) | 0.7 |
| Previous transplant (%) | 33 | 16 | 0.4 |
| Time on dialysis (months) | 50 (48) | 50 (45) | 0.6 |
| Dialysis time (hours/week) | 11.4 (0.9) | 11.7 (0.5) | 0.3 |
| Calcium dialysate (mmol/L) | 1.59 (0.91) | 1.53 (0.84) | 0.8 |
| iPTH baseline | 419 (275; 548) | 417 (352; 622) | 0.5 |
| Cinacalcet dose (mg/d) | 31.6 (13.4) | 42.0 (20.8) | 0.1 |
| Cinacalcet taking adherence | 93.7 (3.3) | 84.4 (5.4) | 0.1 |
| PO4-chelators (n) | 1.1 (0.6) | 1.2 (1.2) | 0.7 |
| Active Vit. D3 (calcitriol) (mcg/week) | 1 (0.3) |
1.3 (0.5) |
0.7 |
| Active Vit. D3 (paricalcitol) (mcg/week) | 0 |
6 (3) |
<0.05 |
| Inactive Vit. D3 (UI/week) | 2179 (4078) | 1597 (3351) | 0.5 |
Values are expressed as mean (standard deviations) or median (25th; 75th percentile) as appropriate.